About the event
The World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 250 speakers, multiple streams and over 1500 attendees from pharma, biotech and payers/HTA’s.
The 2026 edition will take place over two days with 10 tracks: Real World Evidence & Data, Market Access, Pricing, HTA, Pre-Launch Success, Reimbursement, Rare Diseases, AI & Digital Transformation, Health Economics & Outcomes Research, Sustainable Access & Policy.
The 2026 edition will take place over two days with 10 tracks: Real World Evidence & Data, Market Access, Pricing, HTA, Pre-Launch Success, Reimbursement, Rare Diseases, AI & Digital Transformation, Health Economics & Outcomes Research, Sustainable Access & Policy.
Meet our experts in Amsterdam at Cencora‘s booth #605
Casper Paardekooper
Head of Pricing, Policy & Stakeholder Engagement
David Ringger
Director, Global Market Access & Pricing
Herbert Altmann
VP Market Access & Healthcare Consulting
Why partner with Cencora?
We specialize in uncovering evidence and proving your brand's value — helping you navigate the evolving global marketplace and optimize your drug commercialization journey from pre-launch to product maturity.
Our teams of science and research experts bring deep technical expertise, global reach, and strong local market knowledge. By leveraging real-world evidence, pricing strategy, value demonstration, and regulatory pathways tailored to each product type, we help streamline approvals and accelerate market access.
Our teams of science and research experts bring deep technical expertise, global reach, and strong local market knowledge. By leveraging real-world evidence, pricing strategy, value demonstration, and regulatory pathways tailored to each product type, we help streamline approvals and accelerate market access.
